Literature DB >> 10899831

Significantly increased expression of beta-glucuronidase in the central nervous system of mucopolysaccharidosis type VII mice from the latency-associated transcript promoter in a nonpathogenic herpes simplex virus type 1 vector.

J Zhu1, W Kang, J H Wolfe, N W Fraser.   

Abstract

Herpes simplex virus (HSV) has the ability to establish life-long latent infections in postmitotic neurons and to remain transcriptionally active, continuously expressing latency-associated transcripts (LAT) while producing minimal disease. These properties have made HSV an excellent candidate for neuronal gene transfer. Previously, we have shown that in mucopolysaccharidosis type VII mice (MPS VII, beta-glucuronidase deficiency) the LAT promoter is capable of expressing beta-glucuronidase (GUSB) in the trigeminal ganglion and the brainstem after latency is established. However, the number of neurons expressing GUSB is much lower than the number expressing 2-kb LAT following a wild-type virus infection. In this study, we have evaluated the effect of the position of the coding sequence relative to the LAT promoter on beta-glucuronidase gene expression in the central nervous system (CNS). Non-neurovirulent (ICP-34.5-deleted HSV-1) vectors were used, allowing direct intracranial injection. Significantly more GUSB activity was detected in brains of MPS VII mice inoculated with a recombinant virus (HSV-LAT-GUSB-JS) in which the GUSB cDNA was inserted near the LAT promoter, compared to viruses where it was inserted farther downstream in either the LAT exon 1 or overlapping exon 1 and the 2-kb LAT intron. This vector produced more than 100 times the number of positive cells than the other constructs. During acute infection, the distribution of viral replication differed from the distribution of GUSB enzyme expression. Viral antigen was predominately present in cells around the site of injection in the caudate putamen and in ependymal cells lining the ventricles. In contrast, GUSB expression was present mainly in cells of the thalamus and hypothalamus, which did not exhibit viral antigen, suggesting that GUSB enzyme activity was expressed from latently but not acutely infected neuronal cells. This vector design should be useful for high-level expression of various genes in the CNS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10899831     DOI: 10.1006/mthe.2000.0093

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  5 in total

1.  Infection and establishment of latency in the dog brain after direct inoculation of a nonpathogenic strain of herpes simplex virus-1.

Authors:  S L Springer; C H Vite; A C Polesky; S Kesari; N W Fraser; J H Wolfe
Journal:  J Neurovirol       Date:  2001-04       Impact factor: 2.643

2.  In Situ Hybridization for Detection of AAV-Mediated Gene Expression.

Authors:  Jacqueline E Hunter; Brittney L Gurda; Sea Young Yoon; Michael J Castle; John H Wolfe
Journal:  Methods Mol Biol       Date:  2019

Review 3.  CNS-directed gene therapy for lysosomal storage diseases.

Authors:  Mark S Sands; Mark E Haskins
Journal:  Acta Paediatr       Date:  2008-04       Impact factor: 2.299

4.  Deletion of the Virion Host Shut-off Gene Enhances Neuronal-Selective Transgene Expression from an HSV Vector Lacking Functional IE Genes.

Authors:  Yoshitaka Miyagawa; Gianluca Verlengia; Bonnie Reinhart; Fang Han; Hiroaki Uchida; Silvia Zucchini; William F Goins; Michele Simonato; Justus B Cohen; Joseph C Glorioso
Journal:  Mol Ther Methods Clin Dev       Date:  2017-06-16       Impact factor: 6.698

5.  Bilateral single-site intracerebral injection of a nonpathogenic herpes simplex virus-1 vector decreases anxiogenic behavior in MPS VII mice.

Authors:  Wenpei Liu; Gerald Griffin; Trena Clarke; Michael K Parente; Rita J Valentino; John H Wolfe; Nigel W Fraser
Journal:  Mol Ther Methods Clin Dev       Date:  2015-01-28       Impact factor: 6.698

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.